Basit öğe kaydını göster

SYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICATION

dc.contributor.authorKARAKAN, TARKAN
dc.contributor.authorSahin, Onder
dc.contributor.authorKonur, Sevki
dc.contributor.authorErdem, Emrullah
dc.contributor.authorDal, Mehmet Sinan
dc.contributor.authorSenates, Ebubekir
dc.contributor.authorYesil, Atakan
dc.contributor.authorAkdogan, Mehmet Fatih
dc.date.accessioned2021-03-04T10:35:53Z
dc.date.available2021-03-04T10:35:53Z
dc.date.issued2013
dc.identifier.citationSahin O., Yesil A., Senates E., Akdogan M. F. , Konur S., Erdem E., Dal M. S. , KARAKAN T., "SYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICATION", ACTA MEDICA MEDITERRANEA, cilt.29, sa.3, ss.569-573, 2013
dc.identifier.issn0393-6384
dc.identifier.othervv_1032021
dc.identifier.otherav_6dfff605-f46d-4461-a2d9-fe14ae57f475
dc.identifier.urihttp://hdl.handle.net/20.500.12627/75955
dc.description.abstractBackground: Probiotics are used in combinations of H. pylori eradication regimens with variable results. Many strains tested had shown positive effects on side effect profiles. However, a clear effect on eradication rate is studied thoroughly. We aimed to investigate the beneficial effect of a synbiotic combination in clarithromycin-based triple eradication therapy.
dc.language.isoeng
dc.subjectTıp
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleSYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICATION
dc.typeMakale
dc.relation.journalACTA MEDICA MEDITERRANEA
dc.contributor.departmentIstanbul Haydarpasa Numune Training & Research Hospital , ,
dc.identifier.volume29
dc.identifier.issue3
dc.identifier.startpage569
dc.identifier.endpage573
dc.contributor.firstauthorID207773


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster